A fortress-balance-sheet luxury beauty compounder temporarily mispriced as a cyclical fragrance house.
Overview
Puig Brands SA is a century-old, Barcelona-headquartered, family-controlled luxury beauty group that has evolved from a regional cosmetics distributor into a global leader in premium fragrance, prestige makeup, and high-end skincare. The company completed a major IPO on May 3, 2024, listing Class B shares in Spain at €24.50 for an implied valuation around €13.9B, yet governance remains tightly held through a dual-class structure: the Puig family (via Exea Empresarial) retains ~74% of economic interest and ~93.78% of voting rights, prioritizing long-term control and continuity. In FY2025, Puig produced record net revenues of €5.042B across three segments: Fragrance & Fashion (the profit and revenue foundation at ~72% of sales, €3.646B), Makeup (~17%, €844.8M, driven by Charlotte Tilbury acquired in 2020), and Skincare (~11%, €551.2M, spanning dermatological and wellness brands such as Uriage, Apivita, Dr. Barbara Sturm, plus exposure to ISDIN via a 50% JV stake). The portfolio includes wholly owned “Love Brands” (Rabanne, Carolina Herrera, Jean Paul Gaultier, Nina Ricci, Dries Van Noten) and ultra-premium niche fragrance assets (Byredo, Penhaligon’s, L’Artisan Parfumeur), complemented by selective licensing/royalty arrangements (e.g., Christian Louboutin). Puig sells in 150+ countries with operations in 32, with revenue concentrated in EMEA (€2.752B), followed by the Americas (€1.760B) and a smaller but fastest-growing APAC base (€531M). Distribution is deliberately curated across prestige department stores, selective specialty retailers, travel retail, and growing DTC/e-commerce partnerships, designed to protect luxury positioning and pricing power.